Ecto-hydrolysis of adenine nucleotides in rat blood platelets are altered by ovariectomy

Platelets

Volumn 16, Issue 6, 2005, Pages 334-339

  Pochmann, Daniela ^a   Böhmer, Ana Elisa ^a   Bruno, Alessandra Nejar ^a   Sarkis, João J F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Adenine nucleotides; Cardiovascular disease; Ecto 5 nucleotidase; Ecto ATP diphosphohydrolase; Steroid hormones

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; ECTO 5' NUCLEOTIDASE; ESTRADIOL; ESTROGEN; SEX HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME REGULATION; ESTROGEN THERAPY; FEMALE; HEMOSTASIS; HORMONE DEFICIENCY; HYDROLYSIS; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS; VASODILATATION;

5'-NUCLEOTIDASE; ADENINE NUCLEOTIDES; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; BLOOD PLATELETS; CELL MEMBRANE; ENZYME ACTIVATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HYDROLYSIS; OVARIECTOMY; RATS; RATS, WISTAR;

ANIMALIA; THROMBUS;

EID: 27144436403     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500124400     Document Type: Article

References (50)

1. Barret-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991;265:1861-1867.
2. Tostes RC, et al. Effects of estrogen on the vascular system. Braz J Med Biol Res 2003;36(9):1143-1158.
3. White RE. Estrogen and vascular function. Gen Pharmacol 2002;38:1-8.
4. Bar J, Tepper R, Fuchs M, Pardo J, Ovadia J. The effect of replacement therapy on platelet aggregation and ATP release in postmenopausal women. Obstet Gynecol 1993;81:261-264.
5. Barret-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
6. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. New Engl J Med 1987; 316:1105-1110.
7. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. New Engl J Med 1991;325:756-762.
8. Hirata K, Shimada K, Watanabe H, Muro T, Yoshiyama M, Takeuchi K, Hozumi T, Yoshikawa J. Modulation of coronary flow velocity reserve by gender, menstrual cycle and hormone replacement therapy. J Am Coll Cardiol 1991; 38:1879-1884.
9. Ross R, Glomset JA. The pathogenesis of atherosclerosis: Part 1. New Engl J Med 1976;295:369-377.
10. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 1992;326:310-318.
11. Ross R. Atherosclerosis - An inflammatory disease. New Engl J Med 1999;340:115-126.
12. Bar J, Lahav J, Hod M, Ben-Rafael Z, Weinberger I, Brosens J. Regulation of platelet aggregation and adenosine triphosphate release in vitro by 17β-estradiol and medroxyprogesterone acetate in postmenopausal women. Thrombosis and Haemostasis 2000;84:695-700.
13. Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989;65:531-537.
14. Ralevic V, Burnstock G. Involvement of purinergic signaling in cardiovascular diseases. Drugs News Perspect 2003;16 (13):133-140.
15. Gachet C. ADP receptors of platelets and their inhibition. Thrombosis and Haemostasis 2001;86:222-232.
16. Burnstock G, Williams M. P2 purinergic receptors: Modulation of cell function and therapeutic potential. J Pharmacol Exp Ther 2000;295(3):862-869.
17. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99:1351-1360.
18. Birk AV, Broekman J, Gladek EM, Robertson HD, Drosopoulos JHF, Marcus AJ, Szeto HH. Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 2002;140(3):166-175.
19. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 2001;52: 44-56.
20. Meyerhof O. The origin of the reaction of Harden and Young in cell-free alcoholic fermentation. J Biol Chem 1945;157: 105-109.
21. Battastini AMO, Rocha JTB, Barcellos CK, Dias RD, Sarkis JJF. Characterization of an ATP diphosphohydrolase (E.C. 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem Res 1991;16:1303-1310.
22. Sarkis JJF, Salto C. Characterization of a synaptosomal ATP diphosphohydrolase from the eletric organ of Torpedo marmorata. Brain Res Bull 1991;26:871-876.
23. Frassetto SS, Dias RD, Sarkis JJF. Characterization of an ATP diphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Mol Cell Biochem 1993;129:47-55.
24. Pilla C, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF. ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 1996;7:225-230.
25. Battastini AMO, Oliveira ED, Moreira CM, Bonan CD, Sarkis JJF, Dias RD. Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5) from rat brain synaptic plasma membranes. Biochem Mol Biol Intern 1995;37:209-219.
26. Oses JP, Cardoso CM, Germano RA, Kirst IB, Rücker B, Fürstenau CR, Wink MR, Bonan CD, Battastini AMO, Sarkis JJF. Soluble NTPDase: An additional system of nucleotide hydrolysis in rat blood serum. Life Sci 2004; 74(26):3275-3284.
27. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JHF, Price VL, Marcus AJ, Maliszewski CR. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 2002; 109:1031-1040.
28. Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ectonucleotidase-1: Implications for ischemic vascular diseases. J Pharmacol Exp Ther 2002;305(1):9-16.
29. Rongen GA, Floras JS, Lenders JW, Thien T, Smits P. Cardiovascular pharmacology of purines. Clin Sci (London) 1997;92(1):13-24.
30. Kawashima Y, Nagasawa T, Ninomiya H. Contribution of ecto-5′- nucleotidase to the inhibition of platelet aggregation by human endothelial cells. Blood 2000;96(6): 2157-2162.
31. Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VA, Mazzanti CM, Schetinger MRC. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 2003;109:189-194.
32. Bruno AN, Oses JP, Amaral O, Coitinho A, Bonan CD, Battastini AMO, Sarkis JJF. Changes in nucleotide hydrolysis in rat blood serum induced by pentylenetetrazol-kindling. Mol Brain Res 2003;114:140-145.
33. 2+-ATPase activity. Biochim Biophys Acta 1999;1437:257-264.
34. Nedeljkovic N, Djordjevic V, Horva A, Nikezic G, Kanazir DT. Effect of steroid hormone deprivation on the expression of ecto-ATPase in distinct brain regions of female rats. Physiol Res 2000;49:419-426.
35. Pochmann D, Rücker B, Battastini AMO, Sarkis JJF. Ovariectomy and estradiol replacement therapy alters the adenine nucleotide hydrolysis in rat blood serum. Thromb Res 2004;114:275-281.
36. Gamaro GD, Prediger ME, Lopes JB, Dalmaz C. Interaction between estradiol replacement and chronic stress on feeding behavior and on serum leptin. Pharmacol Biochem Behav 2003;76:327-333.
37. Brown TJ, MacLusky NJ, Shanabrough M, Naftolin F. Comparison of age and sex-related changes in cell nuclear estrogen-binding capacity and progestin receptor inducion in the rat brain. Endocrinology 1990;126:2965-2972.
38. Luine VN, Richards ST, Wu VY, Beck KD. Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Horm Behav 1998;34:149-162.
39. Hantgan RR. A study of the kinetics of ADP-triggered platelet shape change. Blood 1984;64:896-906.
40. Tangen O, Berman HJ, Marfey P. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh 1971;25:268-278.
41. 2+-ATPase activity. Anal Biochem 1986;157:375-380.
42. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-bye binding. Anal Biochem 1976;72:248-254.
43. Kaczmarek E, Koziak K, Sévigny J, et al. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 1996;271:33116-33122.
44. Pieber M, Valenzuela MA, Kettlun AM, Mancilla M, Aranda E, Collados L, Traverso-Cori A. ATPase-ADPase activities of rat placental tissue. Comp Biochem Physiol 1991; 100B:281-285.
45. Pearson JD, Carleton JS, Gordon JL. Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth muscle cells in culture. Biochem J 1980;190:421-429.
46. De Vente J, Velema J, Zaagsma J. Properties and subcellular localization of adenosine diphosphatase in rat heart. Arch Biochem Biophys 1984;233:180-187.
47. Fleetwood G, Coade SB, Gordon JL, Pearson JD. Kinetics of adenine nucleotide catabolism in coronary circulation of rats. Am J Physiol 1989;256:H1565-H1572.
48. Konishi C, Naito Y, Ohara N. Age-related changes in adenosine 5′-triphosphate-induced constriction of isolated, perfused mesenteric arteries of rats. Life Sci 1999;64: 1265-1273.
49. Puri RN, Colman RW. ADP-induced platelet activation. Crit Ver Biochem Mol Biol 1997;32:437-502.
50. Thijs A, van Baal WM, van der Moren MJ, Kenemans P, Dräger AM, Huijgens PC, Stehouwer CDA. Effects of hormone replacement therapy on blood platelets. Eur J Clin Invest 2002;32:613-618.